Grishma Rane1, Woon-Puay Koh2,3, Madhu Mathi Kanchi1, Renwei Wang4, Jian-Min Yuan4,5, Xueying Wang1,6. 1. 1 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System , Singapore, Singapore . 2. 2 Duke-National University of Singapore Graduate Medical School , Singapore, Singapore . 3. 3 Saw Swee Hock School of Public Health, National University of Singapore , Singapore . 4. 4 Cancer Epidemiology, Prevention and Control Program, The University of Pittsburgh Cancer Institute , Pittsburgh, Pennsylvania. 5. 5 Department of Epidemiology, University of Pittsburgh Graduate School of Public Health , Pittsburgh, Pennsylvania. 6. 6 National University Cancer Institute of Singapore (NCIS) , Singapore .
Abstract
RATIONALE: Leukocyte telomere length (LTL) and plasma homocysteine (HCY) have been independently associated with cardiovascular disease (CVD) morbidity and mortality. However, few studies have investigated the association between LTL and HCY levels. OBJECTIVE: This study investigated the association of LTL with CVD risk factors, including HCY, in an overt CVD-free Singapore Chinese population comprised of middle aged and elderly, the age group at risk of developing CVD. APPROACH: The association of plasma HCY and other CVD biomarkers with LTL were assessed in 100 samples drawn from the Singapore Chinese Health Study (SCHS). SCHS, a population-based cohort, recruited Chinese individuals, aged 45-74 years, between 1993 and 1998. Questionnaire data were collected via face-to-face interviews. Known CVD biomarkers were measured from the blood collected at the time of recruitment, and LTL was measured using the conventional Southern blot method. RESULTS: After adjustment for age, gender, smoking status, education, and dialect, LTL was found to be inversely associated with plasma HCY levels (p for trend=0.014). Serum urate showed a weak association (p for trend=0.056). Other CVD risk factors and nutrients, namely total cholesterol, low-density lipoprotein (LDL), triglycerides and creatinine, high-density lipoprotein (HDL), folate, and vitamin B6 showed the expected trend with LTL, but did not reach statistical significance. CONCLUSION: LTL displayed an inverse association with plasma HCY. This LTL-HCY inverse association in subjects lacking obvious cardiovascular events suggests that telomere length may be an intermediary in the biological mechanism by which elevated HCY leads to CVD.
RATIONALE: Leukocyte telomere length (LTL) and plasma homocysteine (HCY) have been independently associated with cardiovascular disease (CVD) morbidity and mortality. However, few studies have investigated the association between LTL and HCY levels. OBJECTIVE: This study investigated the association of LTL with CVD risk factors, including HCY, in an overt CVD-free Singapore Chinese population comprised of middle aged and elderly, the age group at risk of developing CVD. APPROACH: The association of plasma HCY and other CVD biomarkers with LTL were assessed in 100 samples drawn from the Singapore Chinese Health Study (SCHS). SCHS, a population-based cohort, recruited Chinese individuals, aged 45-74 years, between 1993 and 1998. Questionnaire data were collected via face-to-face interviews. Known CVD biomarkers were measured from the blood collected at the time of recruitment, and LTL was measured using the conventional Southern blot method. RESULTS: After adjustment for age, gender, smoking status, education, and dialect, LTL was found to be inversely associated with plasma HCY levels (p for trend=0.014). Serum urate showed a weak association (p for trend=0.056). Other CVD risk factors and nutrients, namely total cholesterol, low-density lipoprotein (LDL), triglycerides and creatinine, high-density lipoprotein (HDL), folate, and vitamin B6 showed the expected trend with LTL, but did not reach statistical significance. CONCLUSION: LTL displayed an inverse association with plasma HCY. This LTL-HCY inverse association in subjects lacking obvious cardiovascular events suggests that telomere length may be an intermediary in the biological mechanism by which elevated HCY leads to CVD.
Authors: Athanase Benetos; Jeffrey P Gardner; Mahmoud Zureik; Carlos Labat; Lu Xiaobin; Chris Adamopoulos; Mohamed Temmar; Kathryn E Bean; Frédérique Thomas; Abraham Aviv Journal: Hypertension Date: 2004-01-19 Impact factor: 10.190
Authors: R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley Journal: Proc Natl Acad Sci U S A Date: 1992-11-01 Impact factor: 11.205
Authors: Aoife O'Donovan; Matthew S Pantell; Eli Puterman; Firdaus S Dhabhar; Elizabeth H Blackburn; Kristine Yaffe; Richard M Cawthon; Patricia L Opresko; Wen-Chi Hsueh; Suzanne Satterfield; Anne B Newman; Hilsa N Ayonayon; Susan M Rubin; Tamara B Harris; Elissa S Epel Journal: PLoS One Date: 2011-05-13 Impact factor: 3.240
Authors: Karin Luttropp; Louise Nordfors; Dagmara McGuinness; Lars Wennberg; Hannah Curley; Tara Quasim; Helena Genberg; John Sandberg; Isabella Sönnerborg; Martin Schalling; Abdul Rashid Qureshi; Peter Bárány; Paul G Shiels; Peter Stenvinkel Journal: Transplant Direct Date: 2016-11-16
Authors: Irene Pusceddu; Wolfgang Herrmann; Marcus E Kleber; Hubert Scharnagl; Michael M Hoffmann; Brigitte M Winklhofer-Roob; Winfried März; Markus Herrmann Journal: Eur J Nutr Date: 2019-05-25 Impact factor: 5.614